Anticipation builds as Insmed bronchiectasis therapy brensocatib nears Phase III completion:… GlobalData May 13, 2024 Brensocatib is a dipeptidyl peptidase-1 (DPP-1) reversible inhibitor which exhibits anti-inflammatory action through suppressing…
